EUVIMEDEUVIMED entdecken
Crossref

Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus

Billal Tedbirt iD, Alexandre Lemieux iD, Maud Maho-Vaillant iD, Damien Schapman iD, Leopoldine Lebourgeois iD, Vivien Hébert iD, Olivier Boyer iD, Sébastien Calbo iD, Pascal Joly iD, Marie-Laure Golinski iD

British Journal of Dermatology · 19.05.2026 · 194 (6) · 1182-1184

DOI: 10.1093/bjd/ljag093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 10.03.2026. Verfasst von Billal Tedbirt und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Rouen Normandie, Inserm, Normandie University, PANTHER UMR 1234, CHU Rouen, Department of Dermatology, Rouen, France. Die Arbeit nennt 8 Literaturangaben. Gefördert von: Rouen University Hospital.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-muscarinic-acetylcholine-receptor-subtype-M3 (anti-M3AchR) and anti-secretory-pathway-Ca2+/Mn2+-ATPase-isoform-1 (anti-SPCA1) autoantibodies have been suggested as potential targets in pemphigus. However, their role during the course of pemphigus remains poorly characterized. The objective of the study was to determine the frequency, evolution and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus. Anti-SPCA1 and anti-M3AchR IgG were detected in almost one-third of sera from patients with pemphigus. We demonstrated their in vitro pathogenic activity, alone or in combination. Anti-SPCA1 and anti-M3AchR autoantibodies were associated with a higher risk of relapse and may help clinicians in patient management.

Autor:innen und Institutionen

  • University of Rouen Normandie, Inserm, Normandie University, PANTHER UMR 1234, CHU Rouen, Department of Dermatology, Rouen, France.
  • University of Rouen Normandie, Normandie University, PRIMACEN, Rouen, France.
  • University of Rouen Normandie, Inserm, Normandie University, PANTHER UMR 1234, Rouen, France.
  • University of Rouen Normandie, Inserm, Normandie University, PANTHER UMR 1234, CHU Rouen, Department of Immunology and Biotherapy, Rouen, France.

ORCID-Profile: Billal Tedbirt, Alexandre Lemieux, Maud Maho-Vaillant, Damien Schapman, Leopoldine Lebourgeois, Vivien Hébert, Olivier Boyer, Sébastien Calbo, Pascal Joly, Marie-Laure Golinski

Förderung

  • Rouen University Hospital

Zitieren

APA

Tedbirt, B., Lemieux, A., Maho-Vaillant, M., Schapman, D., Lebourgeois, L., Hébert, V., Boyer, O., Calbo, S., Joly, P., & Golinski, M. L. (2026). Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus. British Journal of Dermatology, 194(6), 1182-1184. https://doi.org/10.1093/bjd/ljag093

Vancouver

Tedbirt B, Lemieux A, Maho-Vaillant M, Schapman D, Lebourgeois L, Hébert V, et al. Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus. British Journal of Dermatology. 2026;194(6):1182-1184. doi:10.1093/bjd/ljag093

BibTeX
@article{Tedbirt2026,
  author = {Tedbirt, Billal and Lemieux, Alexandre and Maho-Vaillant, Maud and Schapman, Damien and Lebourgeois, Leopoldine and Hébert, Vivien and Boyer, Olivier and Calbo, Sébastien and Joly, Pascal and Golinski, Marie-Laure},
  title = {Prevalence and pathogenicity of anti-SPCA1 and anti-M3AchR autoantibodies in pemphigus},
  journal = {British Journal of Dermatology},
  year = {2026},
  volume = {194},
  number = {6},
  pages = {1182--1184},
  doi = {10.1093/bjd/ljag093}
}
Kostenlos starten →